Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

RGS9-2 is a negative modulator of mu-opioid receptor function.

Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, Gold SJ, Zachariou V.

J Neurochem. 2007 Oct;103(2):617-25. Epub 2007 Aug 23.

2.

Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses.

Li S, Lee ML, Bruchas MR, Chan GC, Storm DR, Chavkin C.

Mol Pharmacol. 2006 Nov;70(5):1742-9. Epub 2006 Aug 16.

3.

Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures.

Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, Williams JT.

J Neurosci. 2006 Apr 12;26(15):4118-25.

4.

Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.

Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, Greengard P.

Neuroscience. 2006 Jul 7;140(3):897-911.

PMID:
16600521
5.

Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action.

Kim KS, Lee KW, Lee KW, Im JY, Yoo JY, Kim SW, Lee JK, Nestler EJ, Han PL.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3908-13. Epub 2006 Feb 28.

6.

Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference.

Valjent E, Corbillé AG, Bertran-Gonzalez J, Hervé D, Girault JA.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2932-7. Epub 2006 Feb 10.

7.

An essential role for DeltaFosB in the nucleus accumbens in morphine action.

Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, Berton O, Sim-Selley LJ, Dileone RJ, Kumar A, Nestler EJ.

Nat Neurosci. 2006 Feb;9(2):205-11. Epub 2006 Jan 15.

PMID:
16415864
9.

Morphine promotes rapid, arrestin-dependent endocytosis of mu-opioid receptors in striatal neurons.

Haberstock-Debic H, Kim KA, Yu YJ, von Zastrow M.

J Neurosci. 2005 Aug 24;25(34):7847-57.

10.

Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors.

Wang X, Zeng W, Soyombo AA, Tang W, Ross EM, Barnes AP, Milgram SL, Penninger JM, Allen PB, Greengard P, Muallem S.

Nat Cell Biol. 2005 Apr;7(4):405-11. Epub 2005 Mar 27.

PMID:
15793568
11.

Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors.

Wang Q, Zhao J, Brady AE, Feng J, Allen PB, Lefkowitz RJ, Greengard P, Limbird LE.

Science. 2004 Jun 25;304(5679):1940-4.

12.

Subcellular distribution of neurabin immunolabeling in primate prefrontal cortex: comparison with spinophilin.

Muly EC, Allen P, Mazloom M, Aranbayeva Z, Greenfield AT, Greengard P.

Cereb Cortex. 2004 Dec;14(12):1398-407. Epub 2004 Jun 24.

PMID:
15217898
13.

Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery.

Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS.

Mol Pharmacol. 2004 Jul;66(1):106-12.

14.

Mu opioid receptor: a gateway to drug addiction.

Contet C, Kieffer BL, Befort K.

Curr Opin Neurobiol. 2004 Jun;14(3):370-8. Review.

PMID:
15194118
15.
16.
17.

G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.

Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, Lefkowitz RJ, Chavkin C.

Br J Pharmacol. 2004 Jan;141(1):55-64. Epub 2003 Dec 8.

18.

Local gene knockdown in the brain using viral-mediated RNA interference.

Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ.

Nat Med. 2003 Dec;9(12):1539-44. Epub 2003 Nov 23.

19.

Essential role for RGS9 in opiate action.

Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13656-61. Epub 2003 Oct 31.

20.

Supplemental Content

Support Center